华润医药(03320)：华润三九前三季度净利润约28.99亿元，同比减少10.65%

Group 1 - The core viewpoint of the article is that China Resources Pharmaceutical (03320) reported its financial performance for the first three quarters of 2025, showing a mixed result with revenue growth but a decline in net profit [1] Group 2 - The total operating revenue for the first three quarters is approximately 21.986 billion yuan, representing a year-on-year increase of 11.38% [1] - The net profit for the same period is approximately 2.899 billion yuan, reflecting a year-on-year decrease of 10.65% [1]